Saturday 17 October 2026
Export SHPH’s income statement to Excel — free account
Shuttle Pharmaceuticals Holdings, Inc.
SHPH Healthcare Drug Manufacturers Specialty & Generic
In the quarter to June 2026, EPS grew 90.6% and free cash flow grew 82.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
5.08
0.49
−8.80%
Follow SHPH
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
1.66 | 0.06 | 0.30 | 0.11 |
Net Debt/EBITDA |
0.93 | 0.13 | 0.69 | 0.03 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.12 | 0.37 | 1.12 | 0.18 | |
Capex/Depreciation |
0.00 | (0.04) | (0.06) | (0.06) | |
Interest Coverage |
(119.94) | (152.36) | (183.21) | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.94 | 0.78 | 0.38 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(11.76) | (6.01) | (4.88) | (0.59) | |
Cash per Share |
9.38 | 2.04 | 2.17 | 0.09 | |
Shareholders Equity per Share |
6.24 | 13.76 | 6.65 | 18.90 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.24 | 13.76 | 6.65 | 18.90 | |
Free Cash Flow |
(2.63) | (0.98) | (2.45) | (0.60) | |
Working Capital |
1.30 | (7.46) | (5.84) | (3.08) | |
Capital Expenditures |
— | (0.01) | (0.04) | (0.04) | |
Net Current Asset Value |
1.12 | (7.72) | (6.00) | (3.23) | |
| Other line items | |||||
Quick Ratio |
1.07 | 0.04 | 0.13 | 0.03 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(11.76) | (5.94) | (4.80) | (0.56) | |
Capex per Share |
0.00 | (0.07) | (0.07) | (0.04) | |
Average Payables |
1.41 | 1.03 | 1.34 | 1.98 | |
Average Assets |
2.11 | 6.49 | 8.56 | 14.16 | |
Average Common Equity |
0.04 | 1.48 | 3.32 | 11.39 | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 2 Oct 2026